Dave Ricks was named senior vice president and president of Lilly Bio-Medicines in January 2012, and is a member of the company’s executive committee.
As president of Lilly Bio-Medicines, Ricks leads Bio-Medicines commercialization efforts for marketed medicines in more than 20 countries, along with half of Lilly’s late-stage drug development pipeline (Alzheimer’s disease, immunology and chronic pain). A 20-year Lilly veteran, Ricks previously led three of Lilly’s most important affiliates: the U.S., China, and Canada. He served as president of Lilly USA, the company’s largest affiliate, from 2009 to 2011.
Ricks earned a bachelor’s degree in industrial management from Purdue University in 1990, and an MBA from Indiana University in 1996. He has also worked for Hewlett Packard Corporation and IBM.
Active in trade issues between the United States and European Union, Ricks has served as the U.S. co-chair of the Trans-Atlantic Business Dialogue, and Chairman of the International Board Sponsored Committee of EFPIA (the European Federation of Pharmaceutical Industries and Associations). He also serves as chair of the Riley Children’s Foundation Board of Governors and is the 2015-16 Campaign Chair for United Way of Central Indiana. Ricks also sits on the Purdue Weldon School of Biomedical Engineering Advisory Board.
In his time away from work, he enjoys backpacking, jogging and spending time with his family. Ricks and his wife, Christina, have three children.